Codexis, Inc.

200 Penobscot Drive
Redwood City, CA 94063
United States

Tel: 650-421-8100

Featured Employer
Show jobs for this employer

About Codexis, Inc.

Codexis is a leading enzyme engineering company leveraging our proprietary CodeEvolver® technology platform to discover and develop novel, high performance enzymes for three healthcare industry pillars: pharmaceutical manufacturing, life sciences, and biotherapeutic discovery & development. The enzymes we produce aim to solve real-world challenges associated with small molecule pharmaceuticals manufacturing, nucleic acid synthesis and genomic sequencing, and - as biotherapeutic candidates - they have the potential to treat challenging diseases. To meet this goal, we look for individuals who are driven, eager to grow and ready to embrace meaningful challenges. We empower employees to be authentic, ambitious, agile and have the courage to take action where they can make a positive impact. Whether you are driven by science, or a different area of expertise, we need you to help us create a brighter future.  

TwitterFacebook

Are you ready to join our mission to fight rare diseases? Are you interested in enhancing protein optimization and production?  Do you have a passion to help people have better quality of life?   Come be part of the Codexis, Inc. team where every day we get to unlock the power of proteins®! 


Codexis uses our world-leading CodeEvolver® protein engineering platform to discover novel therapies for the treatment of genetic disorders and other debilitating disease and to develop custom enzymes for a wide range of applications.  We engineer proteins with high efficacy and safety with the goal of delivering the therapeutic to patients as an enzyme replacement, mRNA, or gene therapy. 


But we can't do it without YOU! 


We are rapidly growing, and we are presently seeking to expand our pipeline and diversify applications of our technology platform.   We have a number of opportunities for passionate scientists that want to do something

108 articles about Codexis, Inc.